Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00162370 · ClinicalTrials.gov registry record · Phase 4
A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease
A Phase 4 study, sponsored by Lantheus Medical Imaging.
- Completed
- Registry status
- Phase 4
- Development phase
- 400
- Enrollment target
NCT00162370: Completed Phase 4 study, sponsored by Lantheus Medical Imaging.
NCT00162370 is a Phase 4 study that has completed, run by Lantheus Medical Imaging. The registered enrollment target is 400 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (23% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00162370, a Phase 4 study, has completed, sponsored by Lantheus Medical Imaging.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 400 participants
- Enrollment target
Study Summary
The study is designed to see if stress echocardiography can be used as a screening exam in peri-, or post-menopausal women with a risk of developing of coronary artery disease and experiencing future cardiac events.
Primary Outcome
Peri- or post-menopausal female participants with an intermediate pre-test likelihood of coronary artery disease (CAD) received a Definity contrast-enhanced stress echocardiography study at baseline using either treadmill exercise or dobutamine stresss. Images were evaluated for wall motion abnormalities. The results were compared to patient history on 2-year and 5-year follow up to identify the potential of stress echocardiography for predicting those at higher risk of experiencing future cardi
Interventions
- DRUG Perflutren Lipid Microsphere Injectable Suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2004-04 |
| Est. Completion | 2012-10 |
| Phase | Phase 4 |
What the finished NCT00162370 record still lists
NCT00162370 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (23% lower).
The record links to 0 conditions, and to 1 intervention - of which Perflutren Lipid Microsphere Injectable Suspension is the first listed.
NCT00162370 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00162370 about?
NCT00162370 is a clinical study titled "A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease". The study is designed to see if stress echocardiography can be used as a screening exam in peri-, or post-menopausal women with a risk of developing of coronary artery disease and experiencing future cardiac events.
What is the current status of trial NCT00162370?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 400 participants. The study started on 2004-04. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00162370?
The interventions under investigation include: Perflutren Lipid Microsphere Injectable Suspension (DRUG).
Who is sponsoring clinical trial NCT00162370?
This trial is sponsored by Lantheus Medical Imaging, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00162370's enrollment target sits among peer trials
400 211th of 2000 higher than 1,784 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia